NanoScrips

Nanoscrips email format

Verified email-pattern data for Nanoscrips is currently limited. You can still use the company insights and contact sections below.
NanoScrips is developing novel, patent pending prodrugs and nanoparticles which significantly enhance the safety and efficacy of respective drugs. This is achieved by covalent binding of active ingredient to polymers via ester links. The drugs are released in the body by the action of esterases over an extended period of time. The current pipeline of candidates are for glaucoma, retinal neurodegeneration, radiation sensitization of tumor (ex: Glioblastoma/Brain cancer), NASH/Liver fibrosis, Ulcerative colitis, Epilepsy and Alzheimer's. The company has one NIH funded grant for testing its efficacy in retinal disorder. NanoScrips has research agreements with the universities and National Institutes.
Looking for a particular NanoScrips employee's phone or email?

Nanoscrips Questions

Explore related pages

Related company profiles:

Top NanoScrips Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant